Inosine-mediated modulation of RNA sensing by Toll-like receptor 7 (TLR7) and TLR8.
RNA-specific adenosine deaminase (ADAR)-mediated adenosine-to-inosine (A-to-I) editing is a critical arm of the antiviral response. However, mechanistic insights into how A-to-I RNA editing affects viral infection are lacking. We posited that inosine incorporation into RNA facilitates sensing of nonself RNA by innate immune sensors and accordingly investigated the impact of inosine-modified RNA on Toll-like receptor 7 and 8 (TLR7/8) sensing. Inosine incorporation into synthetic single-stranded RNA (ssRNA) potentiated tumor necrosis factor alpha (TNF-α) or alpha interferon (IFN-α) production in human peripheral blood mononuclear cells (PBMCs) in a sequence-dependent manner, indicative of TLR7/8 recruitment. The effect of inosine incorporation on TLR7/8 sensing was restricted to immunostimulatory ssRNAs and was not seen with inosine-containing short double-stranded RNAs or with a deoxy-inosine-modified ssRNA. Inosine-mediated increase of self-secondary structure of an ssRNA resulted in potentiated IFN-α production in human PBMCs through TLR7 recruitment, as established through the use of a TLR7 antagonist and Tlr7-deficient cells. There was a correlation between hyperediting of influenza A viral ssRNA and its ability to stimulate TNF-α, independent of 5'-triphosphate residues, and involving Adar-1. Furthermore, A-to-I editing of viral ssRNA directly enhanced mouse Tlr7 sensing, when present in proportions reproducing biologically relevant levels of RNA editing. Thus, we demonstrate for the first time that inosine incorporation into immunostimulatory ssRNA can potentiate TLR7/8 activation. Our results suggest a novel function of A-to-I RNA editing, which is to facilitate TLR7/8 sensing of phagocytosed viral RNA.
Centre for Cancer Research, Monash Institute of Medical Research, Monash University, Clayton, Victoria, Australia.
Soroush T
ST
Sarvestani
Michelle D
MD
Tate
Jessica M
JM
Moffat
Ashley M
AM
Jacobi
Mark A
MA
Behlke
Alistair R
AR
Miller
Simone A
SA
Beckham
Claire E
CE
McCoy
Weisan
W
Chen
Justine D
JD
Mintern
Meredith
M
O'Keeffe
Matthias
M
John
Bryan R G
BR
Williams
Michael P
MP
Gantier
D000241:Adenosine / Q000235:genetics / Q000276:immunology; D000243:Adenosine Deaminase / Q000235:genetics / Q000276:immunology; D000818:Animals; D001483:Base Sequence; D005260:Female; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000235:genetics* / Q000276:immunology; D007251:Influenza, Human / Q000235:genetics / Q000276:immunology* / Q000821:virology*; D007288:Inosine / Q000235:genetics* / Q000276:immunology; D016898:Interferon-alpha / Q000235:genetics / Q000276:immunology; D007963:Leukocytes, Mononuclear / Q000276:immunology / Q000821:virology; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D008969:Molecular Sequence Data; D009690:Nucleic Acid Conformation; D017393:RNA Editing; D012367:RNA, Viral / Q000737:chemistry / Q000235:genetics* / Q000276:immunology; D051199:Toll-Like Receptor 7 / Q000235:genetics / Q000276:immunology*; D051200:Toll-Like Receptor 8 / Q000235:genetics / Q000276:immunology*
D016898:Interferon-alpha; D012367:RNA, Viral; D051199:Toll-Like Receptor 7; D051200:Toll-Like Receptor 8; D007288:Inosine; D000243:Adenosine Deaminase; D000241:Adenosine